RNS: significant discount to the Company's current share price.1 May 2020 15:19
London, UK., 1 May 2020: ValiRx Plc (AIM: VAL), the clinical stage biotechnology company notes the recent movement in its share price.
The Company notes that there has been a significant amount of corporate and clinical activity notified in the past 2 weeks.
As announced on 1 April 2020 the Company is required to raise further funds in the near future in order to meet its working capital requirements. In the event that the Company undertakes a placing it is likely to be at a significant discount to the Company's current share price.
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.